Metastatic prostate cancer: Initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose

Radiology

Volumn 199, Issue 3, 1996, Pages 751-756

  Shreve, Paul D ^a,c   Grossman, H Barton ^b,d   Gross, Milton D ^a,c   Wahl, Richard L ^c  

^a VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Bone neoplasms, radionuclide studies, 40.12163, 40.30; Bone neoplasms, secondary, 30.33, 40.33; Emission CT (ECT), comparative studies; Liver neoplasms, secondary, 761.12163, 761.33; Lymphatic system, neoplasms, 99.33; Prostate, neoplasms, 844.30

Indexed keywords

DIATRIZOATE; FLUORODEOXYGLUCOSE F 18; FLUTAMIDE; LEUPRORELIN; MEGLUMINE DIATRIZOATE; OXIDRONATE TECHNETIUM TC 99M; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER HORMONE THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; LYMPH NODE METASTASIS; PELVIS LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SINGLE BLIND PROCEDURE;

AGED; AGED, 80 AND OVER; BONE AND BONES; BONE NEOPLASMS; CONTRAST MEDIA; DEOXYGLUCOSE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; SOFT TISSUE NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0029888387     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.199.3.8638000     Document Type: Article

References (27)

1. Franks LM. The spread of prostate carcinoma. J Pathol 1956; 72:603-611.
2. Thrupkaew AK, Henkin RE, Quinn JL. False negative bone scans in disseminated metastatic disease. Radiology 1974; 113: 383-386.
3. Hayward SJ, McIvor J, Burdge AH, Jewkes RF, Williams G. Staging of prostatic carcinoma with radionuclide bone scintigraphy and lymphography. Br J Radiol 1987; 60: 79-81.
4. Strijk SP, Debruyne FM, Herman CJ. Lymphography in the management of urologic tumors. Radiology 1983; 146:39-45.
5. Singer J, McClennan BL. The diagnosis, staging, and follow-up of carcinomas of the kidney, bladder, and prostate: the role of cross-sectional imaging. Semin Ultrasound CT MR 1989; 10:481-497.
6. DiChiro G. Positron emission tomography using [18F] fluorodeoxy-glucose in brain tumors: a powerful diagnostic and prognostic tool. Invest Radiol 1986; 22:360-371.
7. Gupta NC, Frank AR, Dwan NA, et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-(F-18]-fluoro-2-deoxy-D-glucose. Radiology 1992; 184: 441-444.
8. Wahl RL, Cody R, Hutchins G, Mudgett E. Positron emission tomographic (PET) scanning of primary and metastatic breast carcinoma with the radio labeled glucose analog 2-[F-18]-fluoro-2-deoxy-D-glucose (FDG): initial clinical evaluation. Radiology 1991; 179: 765-770.
9. Okada J, Yoshikaqa K, Imazeki K, et al. The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis. J Nucl Med 1991; 32:686-691.
10. Kern KA, Brunetti A, Norton JA, et al. Metabolic imaging of human extremity musculoskeletal tumors by PET. J Nucl Med 1988; 29:181-186.
11. Stauss LG, Clorius JH, Schlag P, et al. Recurrence of colorectal tumors: PET evaluation. Radiology 1989; 170:329-332.
12. Wahl RL, Harney J, Hutchins G, Grossman HB. Imaging of renal cancer using FDG PET: pilot animal and human studies. J Urol 1991; 146:1470-1474.
13. Bares R, Klever P, Hauptmann S, et al. F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 1994; 192:79-86.
14. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994; 191:371-377.
15. Newman JS, Francis IR, Kaminski MS, Wahl RL. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT. Radiology 1994; 190:111-116.
16. Critters LS, Francis IR, Zasadny KR, Wahl RL. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma. J Nucl Med 1993; 34:1420-1427.
17. 18F]-FDG using tetrabutylamonium bicarbonate. J Labeled Compounds Radiopharm 1994; 35:165-167.
18. Soloway MS, Hardeman SW, Hickey D, et al. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer 1988; 61:195-202.
19. Zasadny KR, Wahl RL. SUVs of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology 1993; 189:847-850.
20. Bischof DA, Wahl RL. How high a level of FDG abdominal activity is considered normal? (abstr). J Nucl Med 1995; 36(P):106.
21. Wahl RL, Harney JV, Hutchins GD, Grossman HB. PET of genitourinary neoplasms: initial evaluation (abstr). Radiology 1990; 177(P):291.
22. Higashi K, Clavo AC, Wahl RL. Does FDG uptake measure proliferative activity of human cancer cells: in vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med 1993; 34: 414-419.
23. Rege SD, Hoh CK, Glaspy JA. Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose. Cancer 1993; 72:82-90.
24. Dahlbom M, Hoffman EJ, Hoh CK, et al. Whole-body positron emission tomography. I. Methods and performance characteristics. J Nucl Med 1992; 33:1191-1199.
25. Fig LM, Gross MD. Metastatic prostate carcinoma mimicking Paget's disease on bone imaging. Clin Nucl Med 1989; 14: 777-778.
26. Jacobs SC. Spread of prostate cancer to bone. Urology 1983; 4:337-344.
27. Wahl RL, Zasadny KR, Helvie M, Hutchins GD, Weber B, Cody R. Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography (PET): initial evaluation. J Clin Oncol 1993; 11:2102-2111.